Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia

NCT00098124 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00098124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
December 31, 2006
Enrollment
1,200
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia